Another brutal day on Wall Street has called into question whether US stocks can deliver during what is normally one of the strongest times of year. The main problem is with the high-flying technology ...

Opendoor's trading volumes are now nearly half of what they were just six months ago. Despite its fantastic returns, it continues to struggle with profitability. However, the company's new CEO is ...

Vericel's future hinges on scaling MACI, as Epicel and Nexobrid have stalled and face capped demand in niche markets. Read ...